Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA …
S Lane, A Yeomans, S Shakir - BMJ open, 2022 - bmjopen.bmj.com
Objectives To combine spontaneously reported data from multiple countries to estimate
reporting rate, and better understand risk factors for myocarditis and pericarditis following …
reporting rate, and better understand risk factors for myocarditis and pericarditis following …
Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis
Objective To summarise the available evidence on the risk of myocarditis and/or pericarditis
following mRNA COVID-19 vaccination, compared with the risk among unvaccinated …
following mRNA COVID-19 vaccination, compared with the risk among unvaccinated …
Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex
M Patone, XW Mei, L Handunnetthi, S Dixon… - Circulation, 2022 - Am Heart Assoc
Background: Myocarditis is more common after severe acute respiratory syndrome
coronavirus 2 infection than after COVID-19 vaccination, but the risks in younger people and …
coronavirus 2 infection than after COVID-19 vaccination, but the risks in younger people and …
Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
S Le Vu, M Bertrand, MJ Jabagi, J Botton… - Nature …, 2022 - nature.com
Cases of myocarditis and pericarditis have been reported following the receipt of Covid-19
mRNA vaccines. As vaccination campaigns are still to be extended, we aimed to provide a …
mRNA vaccines. As vaccination campaigns are still to be extended, we aimed to provide a …
Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study
Background Case reports suggest that SARS-CoV-2 infection could lead to immune
dysregulation and trigger autoimmunity while COVID-19 vaccination is effective against …
dysregulation and trigger autoimmunity while COVID-19 vaccination is effective against …
Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK
Background Evidence on post-acute sequelae of SARS-CoV-2 (PASC) has shown
inconsistent findings. This study aimed to generate coherent evidence on the post-acute …
inconsistent findings. This study aimed to generate coherent evidence on the post-acute …
Adverse effects of COVID-19 vaccines and measures to prevent them
K Yamamoto - Virology Journal, 2022 - Springer
Abstract Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines
and the waning of immunity with time. The study showed that immune function among …
and the waning of immunity with time. The study showed that immune function among …
Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection
The persisting risk of long-term health consequences of SARS-CoV-2 infection and the
protection against such risk conferred by COVID-19 vaccination remains unclear. Here we …
protection against such risk conferred by COVID-19 vaccination remains unclear. Here we …
Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: a self-controlled case series study
Background This study aims to evaluate the association between thromboembolic events
and hemorrhagic stroke following BNT162b2 and CoronaVac vaccination. Methods Patients …
and hemorrhagic stroke following BNT162b2 and CoronaVac vaccination. Methods Patients …
Effectiveness of molnupiravir and nirmatrelvir–ritonavir in hospitalized patients with COVID-19: a target trial emulation study
Background: Whether hospitalized patients benefit from COVID-19 oral antivirals is
uncertain. Objective: To examine the real-world effectiveness of molnupiravir and …
uncertain. Objective: To examine the real-world effectiveness of molnupiravir and …